ILD
* Click to view the content
1. DeSTILD: Development of a Screening Tool for Interstitial Lung
Disease, (ATS 2025, ERS 2025, NAPCON 2025)
2. Usage of Antifibrotics in the Management of Pulmonary Fibrosis in
India (NAPCON 2023)
3. Survey to Understand the Management of Progressive Pulmonary
Fibrosis in the Real-World Setting – The PROFIBRO Survey (ERS
September 2025, NAPCON 2025)
4. Baseline characteristics of participants in the MYCOHYPE study: the
first randomized controlled trial of mycophenolate mofetil in fibrotic
HP (ERS 2025)
5. Development of a Nationwide Accessible Pulmonary Rehabilitation
Program in India (EC Pulmonology and Respiratory Medicine Journal)